Literature DB >> 7407932

In situ activation of murine macrophages by liposomes containing lymphokines.

W E Fogler, A Raz, I J Fidler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7407932     DOI： 10.1016/0008-8749(80)90440-2

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  13 in total

Review 1.  Effects of immunopotentiating agents on alveolar macrophage properties.

Authors:  B Charley
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1986       Impact factor: 2.268

Review 2.  Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease.

Authors:  I J Fidler; G Poste
Journal:  Springer Semin Immunopathol       Date:  1982

Review 3.  Particle-mediated delivery of cytokines for immunotherapy.

Authors:  David A Christian; Christopher A Hunter
Journal:  Immunotherapy       Date:  2012-04       Impact factor: 4.196

4.  Prophylaxis and treatment of experimental lung metastases in mice after treatment with liposome-encapsulated 6-O-stearoyl-N-acetylmuramyl-L-alpha-aminobutyryl-D-isoglutamine.

Authors:  G Lopez-Berestein; L Milas; N Hunter; K Mehta; E M Hersh; C G Kurahara; M Vandupas; D A Eppstein
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

5.  Biological activity of liposome-encapsulated murine interferon gamma is mediated by a cell membrane receptor.

Authors:  D A Eppstein; Y V Marsh; M van der Pas; P L Felgner; A B Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon.

Authors:  W C Koff; W E Fogler; J Gutterman; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

7.  Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2.

Authors:  S R Zhang; R R Salup; P E Urias; T A Twilley; J E Talmadge; R B Herberman; R H Wiltrout
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.

Authors:  E S Kleinerman; A J Schroit; W E Fogler; I J Fidler
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

9.  Lysis of herpesvirus-infected cells by macrophages activated with free or liposome-encapsulated lymphokine produced by a murine T cell hybridoma.

Authors:  W C Koff; S D Showalter; D A Seniff; B Hampar
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

10.  Optimization and limitations of systemic treatment of murine melanoma metastases with liposomes containing muramyl tripeptide phosphatidylethanolamine.

Authors:  I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.